Could a new blood filter save more lives in septic shock?

NCT ID NCT07539883

Recruiting now Disease control Sponsor: Seoul National University Bundang Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a special blood filter called oXiris helps people with septic shock and kidney failure survive. Researchers will review medical records of 360 adults in the ICU who needed continuous blood filtering. They will compare those who got the oXiris filter with those who got standard filters, focusing on survival and how quickly patients recover.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: oXiris hemofilter
What this could lead to: If it works, this could point toward a better way to filter blood in septic shock, potentially improving survival and reducing organ failure.
What could go wrong: This is a retrospective study, not a randomized trial, so results may be biased. The oXiris filter is already used, but its survival benefit remains unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury infectious disease with sepsis multiple organ dysfunction syndrome Sepsis toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIORGAN FAILURE SEPSIS SEPTIC SHOCK

Contacts and locations

Locations

Seoul National University Bundang Hospital
RECRUITING

Seongnam-si, Gyeonggi-do, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.